VIPR2 Antikörper (N-Term)
Kurzübersicht für VIPR2 Antikörper (N-Term) (ABIN2385581)
Target
Alle VIPR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 95-123, N-Term
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- VIPR2, NT (VIPR2, VIP2R, Vasoactive intestinal polypeptide receptor 2, Helodermin-preferring VIP receptor, Pituitary adenylate cyclase-activating polypeptide type III receptor, VPAC2)
-
Aufreinigung
- Purified by Protein A affinity chromatography
-
Immunogen
- KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 95-123 in the N-terminal region of human VIPR2, UniProt Accession #P41587.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
-
Andere Bezeichnung
- VIPR2
-
NCBI Accession
- NP_003373
-
UniProt
- P41587
-
Pathways
- cAMP Metabolic Process
Target
-